Evaluating the effect of Valerian on irritable bowel syndrome

Phase 3

Recruiting

Conditions: Symptoms Severity and quality of life in patients with irritable bowel syndrome.
Other and unspecified irritable bowel syndrome
k58.8

Registration Number: IRCT20210427051098N3

Lead Sponsor: Yazd University of Medical Sciences

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: Recruiting

Sex: All

Target Recruitment: 50

Inclusion Criteria

1- Age 25 to 65 years
2- Patients with irritable bowel syndrome according to the diagnosis of a gastroenterologist according to ROME-IV criteria

Exclusion Criteria

Dietary changes during the study
Unwillingness to continue attending the study
Pregnancy or breastfeeding during the study
Hospitalization
Suffering from certain diseases such as any active stomach-enteric disease or taking certain medicines
Having an allergy to herbal products

Study & Design

Study Type: interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Symptoms severity of irritable bowel syndrome. Timepoint: At the beginning of the study and after 8 weeks of intervention. Method of measurement: IBS-Severity Scoring System (IBS-SSS) questionnaire.;The quality of life in patients with irritable bowel syndrome. Timepoint: At the beginning of the study and after 8 weeks of intervention. Method of measurement: Irritable Bowel Syndrome Quality of Life Questionnaire.

Secondary Outcome Measures

Name	Time	Method
Anxiety and depression. Timepoint: At the beginning of the study and after 8 weeks of the intervention. Method of measurement: Hospital Anxiety and Depression Scale questionnaire.;Visceral Sensitivity. Timepoint: At the beginning of the study and after 8 weeks of the intervention. Method of measurement: Visceral Sensitivity Index questionnaire.;Patient Health. Timepoint: At the beginning of the study and after 8 weeks of the intervention. Method of measurement: Patient Health Questionnaire (PHQ)-12.;Sleep quality. Timepoint: At the beginning of the study and after 8 weeks of the intervention. Method of measurement: Pittsburgh Sleep Quality Index questionnaire (PSQI).